Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-κB ligand (RANKL) in bone marrow stromal cells

Molecules and Cells

Volumn 26, Issue 5, 2008, Pages 486-489

  Oh, Sora ^a   Kyung, Tae Wook ^a   Choi, Hye Seon ^a  

^a University of Ulsan   (South Korea)

Author keywords

Bone; Bone marrow stromal cells; Curcumin; Osteoclastogenesis; Receptor activator of nuclear factor B ligand

Indexed keywords

CURCUMIN; INTERLEUKIN 1ALPHA; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; BONE DENSITY; BONE MARROW CELL; CELL ACTIVITY; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; GENE TARGETING; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OXIDATIVE STRESS; PHARMACOLOGICAL BLOCKING; STROMA CELL;

ANIMALS; BONE MARROW CELLS; COCULTURE TECHNIQUES; CURCUMIN; GENE EXPRESSION REGULATION; INTERLEUKIN-1ALPHA; MICE; MICE, INBRED C57BL; OSTEOCLASTS; OSTEOGENESIS; RANK LIGAND; STROMAL CELLS;

CURCUMA LONGA;

EID: 58049107780     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Aggarwal, B.B., Kumar, A., and Bharti, A.C. (2003). Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23, 363-398.
2. Bai, X., Lu, D., Liu, A., Zhang, Z., Li, X., Zou, Z., Zeng, W., Cheng, B., and Luo, S. (2005). Reactive oxygen species stimulates receptor activator of NF-kB ligand expression in osteoblast. J. Biol. Chem. 280, 17497-17506.
3. Bharti, A.C., Takada, Y., and Aggarwal, B.B. (2004). Curcumin (diferuloylmethane). inhibits receptor for activation of nuclear factor-κB ligand induced NF-κB activation in osteoclast precursors and suppress osteoclastogenesis. J. Immunol. 272, 5940-5947.
4. 2 in human bone marrow stroma cells. Biochem. Biophys. Res. Commun. 247, 338-341.
5. Cheng, A.L., Hsu, C.H., Lin, J.K., Hsu, M.M., Ho, Y.F., Shen, T.S., Ko, J.Y., Lin, J.T., Lin, B.R., Ming-Shiang, W., et al. (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21, 2895-2900.
6. Darnay, B.G., Ni, J., Moore, P.A., and Aggarwal, B.B. (1999). Activation of nuclear factor-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF). 6 and NF-"B inducing kinase: identification of a novel TRAF6 interaction motif. J. Biol. Chem. 274, 7724-7731.
7. Eghbali-Fatourechi, G., Khosla, S., Sanyal, A., Boyle, W.J., Lacey, D.L., and Riggs, B.L. (2003). Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J. Clin. Invest. 111, 1221-1230.
8. Fraser, J.H., Helfrich, M.H., Wallace, H.M., and Ralston, S.H. (1996). Hydrogen peroxide, but not superoxide, stimulates bone resorption in mouse calvariae. Bone 19, 223-226.
9. Gradisar, H., Keber, M.M., Pristovsek, P., and Jerala, R. (2007). MD-2 as the target of curcumin in the inhibition of response to LPS. J. Leukoc. Biol. 82, 968-974.
10. Kluth, D., Banning, A., Paur, I., Blomhoff, R., and Brigelius-Flohe, R. (2007). Modulation of pregnane X receptor and electrophile responsive element-mediated gene expression by dietary polyphenolic compounds. Free Radic. Biol. Med. 42, 315-325.
11. Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C., Morony, S., Olivereira-dos-Santos, A.J., Van, G., Itie, A., et al. (1997). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323.
12. Lean, J.M., Davies, J.T., Fuller, K., Jagger, C.J., Kirstein, B., Partington, G.A., Urry, Z.L., and Chamber, T.J. (2003). A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J. Clin. Invest. 112, 915-923.
13. Lee, S.K., and Lorenzo, J.A. (1999). Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast- like cell formation. Endocrinol. 140, 3552-3561.
14. Lee, S.Y., Reichlin, A., Santana, A., Sokol, K.A., Nussenzweig, M.C., and Choi, Y. (1997). TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocytes proliferation and survival. Immunity 7, 703-713.
15. Lin, J.K. (2007). Molecular targets of curcumin. Adv. Exp. Med. Biol. 596, 227-243.
16. Mody, M., Parhami, F., Saraflan, T.A., and Demer, L.L. (2001). Oxidative stress modulates osteoblast differentiation of vascular and bone cells. Free Radic. Biol. Med. 31, 509-519.
17. Nishiumi, S., Yoshida, K., and Ashida, H. (2007). Curcumin suppresses the transformation of an aryl hydrocarbon receptor through its phosphorylation. Arch. Biochem. Biophys. 466, 267-273.
18. Ozaki, K., Kawata, Y., Amano, S., and Hanazawa, S. (2000). Stimulatory effect of curcumin on osteoclasst apoptosis. Biochem. Pharmacol. 59, 1577-1581.
19. Shin, H.H., Kim, S.J., Kang, S.Y., Lee, D.S., and Choi, H.S. (2006a). Soluble glucocorticoid induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells. Bone 39, 716-723.
20. Shin, H.H., Lee, J.E., Lee, E.A., Kwon, B.S., and Choi, H.S. (2006b). Enhanced osteoclastogenesis in 4-1BB-deficient mice caused by reduced interleukin-10. J. Bone Miner. Res. 21, 1907-1912.
21. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M.T., and Martin, T.J. (1999). Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrinol. Rev. 20, 345-357.
22. 2 is crucially involved in lipopolysaccharide-induced osteoclast formation. J. Immunol. 172, 2504-2510.
23. Tai, H., Miyaura, C., Pilbeam, C.C., Tamura, T., Ohsugi, Y., Koishihara, Y., Kubodera, N., Kawaguchi, H., Raisz, L.G., and Suda, T. (1997). Transcriptional induction of cyclooxygenase-2 in osteoblast is involved in interleukin-6-induced osteoclast formation. Endocrinology 138, 2372-2379.
24. Tropel, P., Noel, D., Platet, N., Legrand, P., Benabid, A.L., and Berger, F. (2004). Isolation and characterization of mesenchymal stem cells from adult mouse bone marrow. Exp. Cell Res. 295, 395-406.
25. Uchida, K. (2008). A lipid-derived endogenous inducer of COX-2: a bridge between inflammation and oxidative stress. Mol. Cell 25, 347-351.
26. Wong, B.R., Josien, R., Lee, S.Y., Vologodskaia, M., Steinman, R.M., and Choi, Y. (1998). The TRAF family of signal transducers mediates nuclear factor-κB activation by the TRANCE receptor. J. Biol. Chem. 273, 28355-28359.
27. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95, 3597-3602.